Astrazeneca AZN
NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT

Astrazeneca (AZN) EBT Growth (1y) (2010 - 2026)

Analysis

Astrazeneca (AZN) EBT Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Asml Holding 659.69 Bn 643.71 Bn 5.90 Bn -
2 General Electric 337.12 Bn 327.78 Bn 6.95 Bn 17.25%
3 Astrazeneca 247.89 Bn 242.60 Bn 12.86 Bn -10.49%
4 Citigroup 236.49 Bn -2,065.81 Bn 24.75 Bn -
5 Bhp 220.99 Bn 202.45 Bn - -
6 Rio Tinto 206.31 Bn 201.93 Bn - -
7 Diageo 192.64 Bn 190.61 Bn - -
8 National Grid 165.59 Bn 161.82 Bn - -
9 Unilever 135.28 Bn 128.25 Bn - -
10 Hdfc Bank 119.43 Bn 82.28 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.49%
Mar 31, 2026 15.05%
Dec 31, 2025 746.40%
Sep 30, 2025 77.46%
Jun 30, 2025 30.45%
Mar 31, 2025 21.50%
Dec 31, 2024 -72.24%
Sep 30, 2024 10.65%
Jun 30, 2024 14.80%
Mar 31, 2024 23.78%
Dec 31, 2023 671.47%
Sep 30, 2023 79.18%
Jun 30, 2023 745.34%
Mar 31, 2023 309.04%
Dec 31, 2022 222.33%
Sep 30, 2022 146.08%
Jun 30, 2022 -67.67%
Mar 31, 2022 -65.61%
Dec 31, 2021 -154.50%
Sep 30, 2021 -334.58%